{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:58:09Z","timestamp":1790866689107,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["866411"],"award-info":[{"award-number":["866411"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.isci.2024.111242","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T03:56:40Z","timestamp":1730260600000},"page":"111242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mathematical multi-compartment modeling of chronic lymphocytic leukemia cell kinetics under ibrutinib"],"prefix":"10.1016","volume":"27","author":[{"given":"Melanie","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Bleser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manouk","family":"Groels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Bo\u0161na\u010dki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Chiorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-4552","authenticated-orcid":false,"given":"Carsten","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.111242_bib1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood-2011-10-386417","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in\u00a0vitro and in\u00a0vivo","volume":"119","author":"Ponader","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.111242_bib2","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood-2011-11-390989","article-title":"The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia","volume":"119","author":"de Rooij","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.111242_bib3","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.111242_bib4","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia","volume":"373","author":"Burger","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.111242_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In\u00a0vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.111242_bib6","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1182\/blood-2014-02-554220","article-title":"Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib","volume":"123","author":"Wodarz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.111242_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89904","article-title":"Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib","volume":"2","author":"Burger","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2024.111242_bib8","first-page":"224","article-title":"Prediction of blood volume in normal human adults","volume":"51","author":"Nadler","year":"1962","journal-title":"Surgery"},{"key":"10.1016\/j.isci.2024.111242_bib9","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood-2019-131469","article-title":"In Human Visualization of Ibrutinib-Induced CLL Compartment Shift","volume":"134","author":"Mayerhoefer","year":"2019","journal-title":"Blood Suppl."},{"key":"10.1016\/j.isci.2024.111242_bib10","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1038\/leu.2014.122","article-title":"Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study","volume":"28","author":"Herman","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.111242_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2024.111242_bib12","article-title":"ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies","volume":"10","author":"Chen","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2024.111242_bib15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/bioinformatics\/btx676","article-title":"PESTO: Parameter EStimation TOolbox","volume":"34","author":"Stapor","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.111242_bib17","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btab227","article-title":"AMICI: high-performance sensitivity analysis for large ordinary differential equation models","volume":"37","author":"Fr\u00f6hlich","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.111242_bib13","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1093\/bioinformatics\/bty514","article-title":"Hierarchical optimization for the efficient parametrization of ODE models","volume":"34","author":"Loos","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.111242_bib14","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1093\/bioinformatics\/btz020","article-title":"Benchmark problems for dynamic modeling of intracellular processes","volume":"17","author":"Hass","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.111242_bib16","first-page":"461","article-title":"Estimating the Dimension of a Model","volume":"2","author":"Schw","year":"1978","journal-title":"Ann. Stat."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224024672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224024672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:46:33Z","timestamp":1783460793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224024672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2589004224024672"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.111242","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mathematical multi-compartment modeling of chronic lymphocytic leukemia cell kinetics under ibrutinib","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.111242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111242"}}